Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 168

    1.

    Association of Hemodialysis Treatment Time and Dose With Mortality and the Role of Race and Sex.

    Miller JE, Kovesdy CP, Nissenson AR, Mehrotra R, Streja E, Van Wyck D, Greenland S, Kalantar-Zadeh K.

    Am J Kidney Dis. 2009 Oct 21. [Epub ahead of print]PMID: 19853336 [PubMed - as supplied by publisher]Related articles

    2.

    Renal replacement therapy in the elderly.

    Ye X, Rastogi A, Nissenson AR.

    Clin Geriatr Med. 2009 Aug;25(3):529-42.PMID: 19765494 [PubMed - in process]Related articles

    3.

    Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients.

    Shantouf R, Kovesdy CP, Kim Y, Ahmadi N, Luna A, Luna C, Rambod M, Nissenson AR, Budoff MJ, Kalantar-Zadeh K.

    Clin J Am Soc Nephrol. 2009 Jun;4(6):1106-14. Epub 2009 May 7.PMID: 19423565 [PubMed - indexed for MEDLINE]Related articles

    4.

    Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.

    Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB.

    Clin J Am Soc Nephrol. 2009 Jun;4(6):1051-6. Epub 2009 Apr 30.PMID: 19406957 [PubMed - indexed for MEDLINE]Related articles

    5.

    Applying frail-elderly care principles.

    Katsikas JL, Nelson FV, Bacchus S, Nissenson AR.

    Semin Dial. 2009 Jan-Feb;22(1):22-4. Review. No abstract available. PMID: 19266614 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?

    Kalantar-Zadeh K, Streja E, Miller JE, Nissenson AR.

    Adv Chronic Kidney Dis. 2009 Mar;16(2):143-51. Review.PMID: 19233073 [PubMed - indexed for MEDLINE]Related articles

    7.

    Costs of managing anemia with erythropoiesis-stimulating agents during hemodialysis: a time and motion study.

    Schiller B, Doss S, DE Cock E, Del Aguila MA, Nissenson AR.

    Hemodial Int. 2008 Oct;12(4):441-9.PMID: 19090867 [PubMed - indexed for MEDLINE]Related articles

    8.

    How Can the Outcomes in Elderly Dialysis Patients be Improved?

    Katsikas JL, Nelson FV, Bacchus S, Nissenson AR.

    Semin Dial. 2008 Oct 16. [Epub ahead of print] No abstract available. PMID: 19000108 [PubMed - as supplied by publisher]Related articles

    9.

    High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine.

    Duru OK, Vargas RB, Kermah D, Nissenson AR, Norris KC.

    J Gen Intern Med. 2009 Jan;24(1):86-92. Epub 2008 Nov 6.PMID: 18987917 [PubMed - indexed for MEDLINE]Related articles

    10.

    Chronic kidney disease in the United States: a public policy imperative.

    Rettig RA, Norris K, Nissenson AR.

    Clin J Am Soc Nephrol. 2008 Nov;3(6):1902-10. Epub 2008 Oct 15.PMID: 18922986 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis.

    Streja E, Kovesdy CP, Greenland S, Kopple JD, McAllister CJ, Nissenson AR, Kalantar-Zadeh K.

    Am J Kidney Dis. 2008 Oct;52(4):727-36. Epub 2008 Aug 29.PMID: 18760517 [PubMed - indexed for MEDLINE]Related articles

    12.

    Racial differences in mortality and ESRD.

    Norris K, Mehrotra R, Nissenson AR.

    Am J Kidney Dis. 2008 Aug;52(2):205-8. No abstract available. PMID: 18640483 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

    Locatelli F, Nissenson AR, Barrett BJ, Walker RG, Wheeler DC, Eckardt KU, Lameire NH, Eknoyan G.

    Kidney Int. 2008 Nov;74(10):1237-40. Epub 2008 Jul 2.PMID: 18596731 [PubMed - indexed for MEDLINE]Related articles

    14.

    Race, gender, and socioeconomic disparities in CKD in the United States.

    Norris K, Nissenson AR.

    J Am Soc Nephrol. 2008 Jul;19(7):1261-70. Epub 2008 Jun 4. Review.PMID: 18525000 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Epoetin-associated pure red cell aplasia: past, present, and future considerations.

    McKoy JM, Stonecash RE, Cournoyer D, Rossert J, Nissenson AR, Raisch DW, Casadevall N, Bennett CL.

    Transfusion. 2008 Aug;48(8):1754-62. Epub 2008 May 14. Review.PMID: 18482185 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The normal hematocrit study--follow-up.

    Besarab A, Goodkin DA, Nissenson AR; Normal Hematocrit Cardiac Trial Authors.

    N Engl J Med. 2008 Jan 24;358(4):433-4. No abstract available. PMID: 18216370 [PubMed - indexed for MEDLINE]Related articles

    17.

    Disease management in chronic kidney disease.

    Rastogi A, Linden A, Nissenson AR.

    Adv Chronic Kidney Dis. 2008 Jan;15(1):19-28.PMID: 18155106 [PubMed - indexed for MEDLINE]Related articles

    18.

    Epoetin dosing and dialysis facility ownership.

    Kliger AS, Nissenson AR.

    JAMA. 2007 Aug 22;298(8):861-2; author reply 862-3. No abstract available. PMID: 17712067 [PubMed - indexed for MEDLINE]Related articles

    19.

    Influence of industry on renal guideline development commentary: keeping our eye on the ball and improving chronic kidney disease patient outcomes.

    Nissenson AR.

    Clin J Am Soc Nephrol. 2007 Mar;2(2):205-6. Epub 2006 Dec 13. No abstract available. Erratum in: Clin J Am Soc Nephrol. 2007 May;2(3):617. PMID: 17699409 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Septicemia in patients with ESRD is associated with decreased hematocrit and increased use of erythropoietin.

    Nissenson AR, Dylan ML, Griffiths RI, Yu HT, Dubois RW.

    Clin J Am Soc Nephrol. 2006 May;1(3):505-10. Epub 2006 Mar 22.PMID: 17699252 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    The future of renal replacement therapy.

    Rastogi A, Nissenson AR.

    Adv Chronic Kidney Dis. 2007 Jul;14(3):249-55. Review.PMID: 17603978 [PubMed - indexed for MEDLINE]Related articles

    22.

    The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?

    Fishbane S, Nissenson AR.

    Kidney Int. 2007 Oct;72(7):806-13. Epub 2007 Jun 27. Review.PMID: 17597700 [PubMed - indexed for MEDLINE]Related articles

    23.

    Vascular access for hemodialysis.

    Hayashi R, Huang E, Nissenson AR.

    Nat Clin Pract Nephrol. 2006 Sep;2(9):504-13. Review.PMID: 16941043 [PubMed - indexed for MEDLINE]Related articles

    24.

    Catheter use is high even among hemodialysis patients with a fistula or graft.

    Danese MD, Liu Z, Griffiths RI, Dylan M, Yu HT, Dubois R, Nissenson AR.

    Kidney Int. 2006 Oct;70(8):1482-5. Epub 2006 Aug 30.PMID: 16941025 [PubMed - indexed for MEDLINE]Related articles

    25.

    The case for disease management in chronic kidney disease.

    Chen RA, Scott S, Mattern WD, Mohini R, Nissenson AR.

    Dis Manag. 2006 Apr;9(2):86-92.PMID: 16620194 [PubMed - indexed for MEDLINE]Related articles

    26.

    Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations.

    Dubois RW, Goodnough LT, Ershler WB, Van Winkle L, Nissenson AR.

    Curr Med Res Opin. 2006 Feb;22(2):385-95. Review.PMID: 16466611 [PubMed - indexed for MEDLINE]Related articles

    27.

    Mortality differences among organisms causing septicemia in hemodialysis patients.

    Danese MD, Griffiths RI, Dylan M, Yu HT, Dubois R, Nissenson AR.

    Hemodial Int. 2006 Jan;10(1):56-62.PMID: 16441828 [PubMed - indexed for MEDLINE]Related articles

    28.

    The National Anaemia Action Council, Inc.: the primary North American resource for anaemia education and research.

    Nissenson AR.

    Eur J Clin Invest. 2005 Dec;35 Suppl 3:100-6.PMID: 16281966 [PubMed - indexed for MEDLINE]Related articles

    29.

    Continuously functioning artificial nephron system: the promise of nanotechnology.

    Nissenson AR, Ronco C, Pergamit G, Edelstein M, Watts R.

    Hemodial Int. 2005 Jul;9(3):210-7.PMID: 16191071 [PubMed - indexed for MEDLINE]Related articles

    30.

    Economic burden of anemia in an insured population.

    Nissenson AR, Wade S, Goodnough T, Knight K, Dubois RW.

    J Manag Care Pharm. 2005 Sep;11(7):565-74.PMID: 16137214 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.

    Nissenson AR, Dylan ML, Griffiths RI, Yu HT, Dean BB, Danese MD, Dubois RW.

    Am J Kidney Dis. 2005 Aug;46(2):301-8.PMID: 16112049 [PubMed - indexed for MEDLINE]Related articles

    32.

    The human nephron filter: toward a continuously functioning, implantable artificial nephron system.

    Nissenson AR, Ronco C, Pergamit G, Edelstein M, Watts R.

    Blood Purif. 2005;23(4):269-74. Epub 2005 May 20.PMID: 15908745 [PubMed - indexed for MEDLINE]Related articles

    33.

    Dialysis outcomes as a measure of adequacy of dialysis.

    Butman M, Nissenson AR.

    Semin Nephrol. 2005 Mar;25(2):70-5. Review.PMID: 15791557 [PubMed - indexed for MEDLINE]Related articles

    34.

    Improving outcomes in CKD and ESRD patients: carrying the torch from training to practice.

    Nissenson AR, Agarwal R, Allon M, Cheung AK, Clark W, Depner T, Diaz-Buxo JA, Kjellstrand C, Kliger A, Martin KJ, Norris K, Ward R, Wish J.

    Semin Dial. 2004 Sep-Oct;17(5):380-97. Review.PMID: 15461748 [PubMed - indexed for MEDLINE]Related articles

    35.

    Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment.

    Fishbane S, Kalantar-Zadeh K, Nissenson AR.

    Semin Dial. 2004 Sep-Oct;17(5):336-41.PMID: 15461737 [PubMed - indexed for MEDLINE]Related articles

    36.

    Pure red-cell aplasia and epoetin therapy.

    Bennett CL, Luminari S, Nissenson AR, Tallman MS, Klinge SA, McWilliams N, McKoy JM, Kim B, Lyons EA, Trifilio SM, Raisch DW, Evens AM, Kuzel TM, Schumock GT, Belknap SM, Locatelli F, Rossert J, Casadevall N.

    N Engl J Med. 2004 Sep 30;351(14):1403-8.PMID: 15459301 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Role of sodium and volume in the pathogenesis of hypertension in hemodialysis.

    Wilson J, Shah T, Nissenson AR.

    Semin Dial. 2004 Jul-Aug;17(4):260-4. Review.PMID: 15250914 [PubMed - indexed for MEDLINE]Related articles

    38.

    Economics of clinical nephrology practice.

    Provenzano R, Nissenson AR.

    Am J Kidney Dis. 2004 Jul;44(1):168-78. No abstract available. PMID: 15211450 [PubMed - indexed for MEDLINE]Related articles

    39.

    Restructuring the ESRD payment system in the United States.

    Nissenson AR.

    Kidney Int. 2004 Jul;66(1):466-76. No abstract available. PMID: 15200471 [PubMed - indexed for MEDLINE]Related articles

    40.

    Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature.

    Wilson A, Yu HT, Goodnough LT, Nissenson AR.

    Am J Med. 2004 Apr 5;116 Suppl 7A:50S-57S. Review.PMID: 15050886 [PubMed - indexed for MEDLINE]Related articles

    41.

    Anemia and its clinical consequences in patients with chronic diseases.

    Goodnough LT, Nissenson AR.

    Am J Med. 2004 Apr 5;116 Suppl 7A:1S-2S. No abstract available. PMID: 15050881 [PubMed - indexed for MEDLINE]Related articles

    42.

    Nanotechnology and dialysis.

    Nissenson AR, Ronco C.

    Int J Artif Organs. 2004 Jan;27(1):3-5. No abstract available. PMID: 14984176 [PubMed - indexed for MEDLINE]Related articles

    43.

    The chronic kidney disease initiative.

    Parker TF 3rd, Blantz R, Hostetter T, Himmelfarb J, Kliger A, Lazarus M, Nissenson AR, Pereira B, Weiss J; Council of American Kidney Societies.

    J Am Soc Nephrol. 2004 Mar;15(3):708-16.PMID: 14978173 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    What common practices in dialysis units can be altered to improve patient care?

    Nissenson AR.

    Semin Dial. 2004 Jan-Feb;17(1):12-3. No abstract available. PMID: 14717803 [PubMed - indexed for MEDLINE]Related articles

    45.

    Preface.

    Nissenson AR.

    Hemodial Int. 2004 Jan 1;8(1):1. No abstract available. PMID: 19379392 [PubMed - in process]Related articles

    46.

    Emphasizing patient choice: the modality selection project in ESRD Network 18.

    Mehrotra R, Marsh D, Peters V, Nissenson AR.

    Nephrol News Issues. 2003 Nov;17(12):30-6.PMID: 14640008 [PubMed - indexed for MEDLINE]Related articles

    47.

    Controversies in iron management.

    Nissenson AR, Charytan C.

    Kidney Int Suppl. 2003 Nov;(87):S64-71. Review.PMID: 14531776 [PubMed - indexed for MEDLINE]Related articles

    48.

    Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.

    Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD.

    Am J Kidney Dis. 2003 Oct;42(4):761-73.PMID: 14520627 [PubMed - indexed for MEDLINE]Related articles

    49.

    Disease management improves outcomes in patients with CKD.

    Nissenson AR.

    Nephrol News Issues. 2003 Aug;17(9):15-9. Review. No abstract available. PMID: 12971220 [PubMed - indexed for MEDLINE]Related articles

    50.

    Pure red-cell aplasia: an emerging epidemic in dialysis patients?

    Anand S, Nissenson AR.

    Perit Dial Int. 2003 Jul-Aug;23(4):317-9. No abstract available. PMID: 12968837 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...